JPRN-UMIN000010780已完成未知
Effects of teneligliptin on glycemic control and bone metabolic markers in diabetic patients undergoing hemodialysis - Effects of teneligliptin on glucose and bone metabolism in diabetic patients undergoing hemodialysis
Diamond study group0 个研究点目标入组 10 人开始时间: 2013年5月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with severe liver dysfunction (AST more than 100 or ALT more than 100 IU/L) Patients with malignancy under medical treatmennt Patients with untreated diabetic retinopathy Patients terated with insulin injection Patients disqualified by doctor for any reason
研究者
相似试验
已完成
4 期
The efficacy of teneligliptin in diabetic patients on hemodialysisType2 diabetic patients on hemodialysisJPRN-UMIN000010999Kawashima Hospital30
已完成
不适用
Efficacy of linagliptin on glycemic control in diabetic patients on hemodialysis [Diamond study-1]Diabetic patients on hemodialysisJPRN-UMIN000007635Diamond study group80
已完成
不适用
Effects of one of antidiabetic agents, teneligliptin, on the vascular endothelium function of ACS patients with diabetesAcute Coronary Syndrome (ACS) and diabetesJPRN-UMIN000018936Saitama Medical Center, Jichi Medical University50
已完成
4 期
Efficacy of Sitagliptin on glycaemic control in drug naïve patients with type 2 diabetes (STRICT-2)Type 2 Diabetes MellitusJPRN-UMIN000005460STRICT study Group300
尚未招募
不适用
Study of antidiabetic drugs on markers of inflammation in type 2 diabetes mellitus patients.CTRI/2018/03/012603MALEHA BUT